Navigation Links
Surgery using gene therapy for Alzheimer’s patient

Doctors have performed the first-ever surgical procedure using gene therapy in the brain of an Alzheimer's patient, in an effort to stave off the effects of the debilitating disease, in La Jolla, California.

The groundbreaking 11-hour procedure that took place on April 5 involved implanting genetically engineered cells into the brain of a 60-year-old woman from Oregon.//

The cells, skin cells taken from the patient herself, were engineered to produce a substance called nerve growth factor (NGF). NGF is known to help restore connections between brain cells that deteriorate with aging. The cells were grown in the lab to increase their numbers and genetically modified so that they would produce NGF.
br> The quantity of skin cells implanted amounted to about one hundredth of a teaspoon--or roughly two drops--and were implanted in a region of the brain approximately 1.5 centimeters in area, according to the project leader Dr. Mark H. Tuszynski of the University of California-San Diego and the Veterans Administration.

Dr. Hoi Sang U led the surgical procedure.While the technique is not considered to be a cure for the debilitating illness, Tuszynski is optimistic that the newly inserted NGF-producing genes will take over the role of failing cells and delay the rapid decline of brain function that is associated with Alzheimer's disease.

The research studies of NGF have shown that the chemical substantially prevents the death of cells in the brain and it reverses the atrophy that happens during the aging process.


'"/>




Page: 1

Related medicine news :

1. Bypass Heart Surgery Performed Without General Anesthesia
2. Indian Prime Minister has successful Knee Replacement Surgery
3. Surgery made simple
4. Surgery a safety in senility
5. Breast Cancer Surgery Causes Psychological problems
6. Radiofrequency Energy Cooks Tumors Without Surgery
7. Heart Surgery Is Getting Safer for the Old
8. Surgery-Rigged pulley helps patients
9. Blood Vessel Surgery Safe for Diabetics
10. Ulcer Surgery connected to danger of Pancreatic Cancer
11. Surgery beneficial in Menieres disease
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2017)... ... 28, 2017 , ... Semrock’s highly popular SearchLight Spectra Viewer ... resource for fluorescence microscopists and optical system designers, enabling The Right Solution, Right ... the globe, SearchLight has become a tremendously popular tool for the fluorescence imaging ...
(Date:4/27/2017)... ... April 27, 2017 , ... Thinksport, the leaders in safe, ... award-winning sunscreen they’ve used the same scientific approach to solving smelly, sweaty athletes, ... the aisles that contain harmful chemicals that should be put nowhere near your ...
(Date:4/27/2017)... ... April 27, 2017 , ... Offering the purest product of its ... times purer and more potent than the market has seen before. Swissx uses proprietary ... well as a patented chromatography process for extraction, to produce its CBD oil--maximizing its ...
(Date:4/26/2017)... , ... April 26, 2017 , ... Journal of ... It can have severe consequences to overall dental health, including complications with speech, eating, ... turn to dental implants to replace lost teeth. As the number of tooth replacements ...
(Date:4/26/2017)... ... April 26, 2017 , ... The ... Excellence upon National Registry of Emergency Medical Technicians and welcomes this ... said Dr. Jan G. West, Ph.D. , CEO & Organizational Psychologist at ...
Breaking Medicine News(10 mins):
(Date:4/24/2017)... England , April 24, 2017 ... development, today announced the addition of a major ... ,Validated In-situ Plate Seeding,). The VIPS has been ... and 384 well microplates as part of the ... system offers a simple and more reliable solution ...
(Date:4/20/2017)... 2017 Research and Markets has ... and Market Prospects: Addressing Production Complexities Through Risk Management ... ... Biosimilar Pipeline and Market Prospects: Overcoming Production Complexities Through ... assessment of the current trends in the global biosimilars ...
(Date:4/20/2017)... -- AbbVie (NYSE: ABBV), a global biopharmaceutical company, today ... C virus (HCV) infected patients with genotype 1, ... (Child-Pugh A) achieved sustained virologic response at 12 ... pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high SVR ... of G/P treatment without ribavirin. Patients with specific ...
Breaking Medicine Technology: